Literature DB >> 35548475

Endoscopic bariatrics: current therapies and future directions.

Debashis Reja1, Clark Zhang1, Avik Sarkar2.   

Abstract

Endoscopic bariatric therapies (EBTs) are endoscopic procedures indicated for weight loss in the obese population. They are shown to be safe and effective for patients who do not quality for bariatric surgery. There are currently no randomized controlled studies comparing bariatric surgery with EBTs. However, EBTs are more cost effective and have fewer complications. This review will examine currently available EBTs with published data. 2022 Translational Gastroenterology and Hepatology. All rights reserved.

Entities:  

Keywords:  Bariatric; aspiration; duodenal mucosal resurfacing; duodenal-jejunal bypass liner; endobariatric; endobarrier; endoscopic sleeve gastroplasty; endoscopy; gastro-duodeno-jejunal bypass sleeve; intragastric balloon (IGB); obesity; primary obesity surgery endoluminal (POSE); transoral outlet reduction (TORe); transpyloric shuttle (TPS)

Year:  2022        PMID： 35548475      PMCID： PMC9081914          DOI： 10.21037/tgh.2020.03.09

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


  65 in total

Review 1.  Endoscopic Bariatric Therapies: Intragastric Balloons, Tissue Apposition, and Aspiration Therapy.

Authors:  Joshua A Turkeltaub; Steven A Edmundowicz
Journal:  Curr Treat Options Gastroenterol       Date:  2019-06

Review 2.  Endoscopic Bariatric and Metabolic Therapies: New and Emerging Technologies.

Authors:  Shelby Sullivan; Steven A Edmundowicz; Christopher C Thompson
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

3.  The safety and efficacy of the procedureless intragastric balloon.

Authors:  Salman Alsabah; Eliana Al Haddad; Shehab Ekrouf; Ahmad Almulla; Saud Al-Subaie; Mubarak Al Kendari
Journal:  Surg Obes Relat Dis       Date:  2017-12-09       Impact factor: 4.734

Review 4.  Endoscopic bariatric therapies for treating obesity: a learning curve for gastroenterologists.

Authors:  Vahe Shahnazarian; Daryl Ramai; Avik Sarkar
Journal:  Transl Gastroenterol Hepatol       Date:  2019-03-18

5.  One-year adjustable intragastric balloons: results in 73 consecutive patients in the U.K.

Authors:  J Brooks; E D Srivastava; E M H Mathus-Vliegen
Journal:  Obes Surg       Date:  2014-05       Impact factor: 4.129

6.  The impact of EndoBarrier gastrointestinal liner in obese patients with normal glucose tolerance and in patients with type 2 diabetes.

Authors:  Ulrich Rohde; Cecilie A Federspiel; Peter Vilmann; Ebbe Langholz; Steffen U Friis; Martin Krakauer; Jens F Rehfeld; Jens J Holst; Tina Vilsbøll; Filip K Knop
Journal:  Diabetes Obes Metab       Date:  2016-11-14       Impact factor: 6.577

7.  Gastrointestinal Physiological Changes and Their Relationship to Weight Loss Following the POSE Procedure.

Authors:  J C Espinós; R Turró; G Moragas; A Bronstone; J N Buchwald; F Mearin; A Mata; H Uchima; J Turró; S Delgado-Aros
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

8.  A prospective pilot study of the efficacy and safety of Elipse intragastric balloon: A single-center, single-surgeon experience.

Authors:  Saud Al-Subaie; Salman Khalifa; Waleed Buhaimed; Shahad Al-Rashidi
Journal:  Int J Surg       Date:  2017-10-06       Impact factor: 6.071

9.  Adjustable intragastric balloons: a 12-month pilot trial in endoscopic weight loss management.

Authors:  Evzen Machytka; Pavel Klvana; Asher Kornbluth; Steven Peikin; Lisbeth E M Mathus-Vliegen; Christopher Gostout; Gontrand Lopez-Nava; Scott Shikora; Jeffrey Brooks
Journal:  Obes Surg       Date:  2011-10       Impact factor: 4.129

10.  Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial.

Authors:  Christopher C Thompson; Barham K Abu Dayyeh; Robert Kushner; Shelby Sullivan; Alan B Schorr; Anastassia Amaro; Caroline M Apovian; Terrence Fullum; Amir Zarrinpar; Michael D Jensen; Adam C Stein; Steven Edmundowicz; Michel Kahaleh; Marvin Ryou; J Matthew Bohning; Gregory Ginsberg; Christopher Huang; Daniel D Tran; Joseph P Glaser; John A Martin; David L Jaffe; Francis A Farraye; Samuel B Ho; Nitin Kumar; Donna Harakal; Meredith Young; Catherine E Thomas; Alpana P Shukla; Michele B Ryan; Miki Haas; Heidi Goldsmith; Jennifer McCrea; Louis J Aronne
Journal:  Am J Gastroenterol       Date:  2016-12-06       Impact factor: 10.864
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.